Associate Director, Clinical Site Budgets & Payments

Associate Director, Clinical Site Budgets & Payments

Boston;
Chicago;
San Francisco;
Seattle

About Jade Biosciences

Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE
101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE
201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE
301, an undisclosed antibody candidate, both currently in preclinical development.

Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit  and follow the Company on Linked In.

The Associate Director, Clinical Site Budgets & Payments will architect and lead the company’s global approach to clinical trial site budgeting, investigator grant strategy, transparency compliance, and site/vendor payment governance across our clinical trial portfolio. This leader will define Jade’s global investigator grant philosophy, including structured opening offer and negotiation parameters that ensure speed, fairness, and alignment with global FMV benchmarks.

They will establish standards for invoiceables, conditional procedures, pass‑through costs, and country‑specific budgeting norms that apply across all Jade clinical studies.

This role oversees a full-service CRO partner responsible for operational execution of budgets, payments, reconciliation, and study financial controls. It also builds and maintains global site budget forecasts, ensures just-in-time CRO funding, and supports accruals, reconciliation, and inspection-readiness.

The successful candidate must be equally fluent in clinical trial protocols and financial statements, highly skilled in influencing cross-functional and vendor partners, and able to uphold strict compliance with FMV and Sunshine/Open Payments regulations. This is a high‑visibility, individual‑contributor role reporting directly to the Executive Director, Development Outsourcing and operating globally across all Jade studies. The position is remote, with domestic travel up to four times per year.

Global Payment Philosophy, Compliance & Governance

• Define Jade’s global investigator grant strategy, including opening-offer tiers, decision and negotiation parameters, aligned with international FMV standards.
• Establish and maintain policies for invoiceables, pass-throughs, conditional procedures, screen-fail handling, and complex visit structures; ensure global consistency.
• Develop and maintain SOPs/WIs governing budgeting, payments, documentation, and global transparency requirements (e.g., U.S. Sunshine/Open Payments and ex-US equivalents).
• Define FMV justification expectations and ensure audit-ready documentation across all investigator/HCP engagements.

Study-Level Budget Design & Financial Oversight

• Translate clinical protocols into country-specific and site-level cost models that accurately reflect procedures, visit schedules, and conditional events.
• Build and maintain global study budget forecasts, partnering closely with Clinical Operations and Finance to ensure alignment with development plans.
• Oversee accruals, spend tracking, payment reconciliation, and close-out documentation for accuracy and inspection readiness.

CRO Governance & Issue Escalation

• Serve as Jade’s primary owner of CRO performance for site budgets and payments, including contract expectations, KPIs, and service delivery standards.
• Lead the payment-related components of CRO governance forums, including issue resolution, aging analysis, cycle-time performance reviews, and payment forecasting.
• Resolve escalated site payment issues, driving sustainable root-cause solutions and process improvements.

HCP/KOL Payment Operations (“White-Glove” Model)

• Implement a high-touch service model for KOL/HCP payments (consulting, advisory boards, speaking engagements), ensuring accuracy, speed, and FMV alignment.
• Streamline administrative burden for external experts by…